Multiple exon skipping strategies to by-pass dystrophin mutations
Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Pergamon Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488593/ |
id |
pubmed-3488593 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-34885932013-04-01 Multiple exon skipping strategies to by-pass dystrophin mutations Adkin, Carl F. Meloni, Penelope L. Fletcher, Susan Adams, Abbie M. Muntoni, Francesco Wong, Brenda Wilton, Steve D. Article Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon skipping strategies exist to restore dystrophin expression. However, for some small intra-exonic mutations, a third strategy, not applicable to whole exon deletions, may be possible. The removal of only one frame-shifting exon flanking the mutation-carrying exon may restore the reading frame and allow synthesis of a functional dystrophin isoform, providing that no premature termination codons are encountered. For these mutations, the removal of only one exon offers a simpler, cheaper and more feasible alternative approach to the dual exon skipping that would otherwise be considered. We present strategies to by-pass intra-exonic dystrophin mutations that clearly demonstrate the importance of tailoring exon skipping strategies to specific patient mutations. Pergamon Press 2012-04 /pmc/articles/PMC3488593/ /pubmed/22182525 http://dx.doi.org/10.1016/j.nmd.2011.10.007 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Adkin, Carl F. Meloni, Penelope L. Fletcher, Susan Adams, Abbie M. Muntoni, Francesco Wong, Brenda Wilton, Steve D. |
spellingShingle |
Adkin, Carl F. Meloni, Penelope L. Fletcher, Susan Adams, Abbie M. Muntoni, Francesco Wong, Brenda Wilton, Steve D. Multiple exon skipping strategies to by-pass dystrophin mutations |
author_facet |
Adkin, Carl F. Meloni, Penelope L. Fletcher, Susan Adams, Abbie M. Muntoni, Francesco Wong, Brenda Wilton, Steve D. |
author_sort |
Adkin, Carl F. |
title |
Multiple exon skipping strategies to by-pass dystrophin mutations |
title_short |
Multiple exon skipping strategies to by-pass dystrophin mutations |
title_full |
Multiple exon skipping strategies to by-pass dystrophin mutations |
title_fullStr |
Multiple exon skipping strategies to by-pass dystrophin mutations |
title_full_unstemmed |
Multiple exon skipping strategies to by-pass dystrophin mutations |
title_sort |
multiple exon skipping strategies to by-pass dystrophin mutations |
description |
Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon skipping strategies exist to restore dystrophin expression. However, for some small intra-exonic mutations, a third strategy, not applicable to whole exon deletions, may be possible. The removal of only one frame-shifting exon flanking the mutation-carrying exon may restore the reading frame and allow synthesis of a functional dystrophin isoform, providing that no premature termination codons are encountered. For these mutations, the removal of only one exon offers a simpler, cheaper and more feasible alternative approach to the dual exon skipping that would otherwise be considered. We present strategies to by-pass intra-exonic dystrophin mutations that clearly demonstrate the importance of tailoring exon skipping strategies to specific patient mutations. |
publisher |
Pergamon Press |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488593/ |
_version_ |
1611921250644393984 |